Literature DB >> 11601136

Immunophenotypic analysis of peripheral T-cell neoplasms. A multiparameter flow cytometric approach.

S Jamal1, L J Picker, D B Aquino, R W McKenna, D B Dawson, S H Kroft.   

Abstract

We retrospectively reviewed multiparameter flow cytometric analyses in 50 peripheral T-cell neoplasms (PTCNs). Results were interpreted within the context of a large cohort of nonneoplastic T-cell populations. All PTCN diagnoses were confirmed with morphologic and/or molecular analysis. Aberrant populations were defined as discrete immunophenotypic clusters exhibiting loss of or increased or diminished expression of T-cell antigens relative to internal immunophenotypically normal T-cell populations. An antigenic pattern was considered abnormal if it exceeded ranges for T-cell subsets in specific anatomic sites or was not normally encountered. Forty-six of 50 and 41 of 50 demonstrated 1 or more and 2 or more aberrations, respectively. The most common abnormally expressed antigen was CD3, followed by CD7, CD5, and CD2. Except for CD7, abnormally dim or bright antigen expression was more common than deletion. Only 3 cases were abnormal solely based on expansion of an otherwise immunophenotypically normal population; the remainder had patterns of antigen expression not seen in nonneoplastic populations. These data indicate that most PTCNs are aberrant by multiparameter flow analysis. However, results must be interpreted within the context of thorough knowledge of the immunophenotypic spectrum of nonneoplastic T cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11601136     DOI: 10.1309/QF6N-VAQW-N74H-4JE2

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  24 in total

1.  Flow cytometric immunophenotypic assessment of T-cell clonality by vβ repertoire analysis in fine-needle aspirates and cerebrospinal fluid.

Authors:  Prashant Tembhare; Constance M Yuan; John C Morris; John E Janik; Armando C Filie; Maryalice Stetler-Stevenson
Journal:  Am J Clin Pathol       Date:  2012-02       Impact factor: 2.493

Review 2.  Hematopoietic Cell Transplantation and Adoptive Cell Therapy in Peripheral T Cell Lymphoma.

Authors:  Andrew M Rogers; Jonathan E Brammer
Journal:  Curr Hematol Malig Rep       Date:  2020-08       Impact factor: 3.952

3.  EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes.

Authors:  J J M van Dongen; L Lhermitte; S Böttcher; J Almeida; V H J van der Velden; J Flores-Montero; A Rawstron; V Asnafi; Q Lécrevisse; P Lucio; E Mejstrikova; T Szczepański; T Kalina; R de Tute; M Brüggemann; L Sedek; M Cullen; A W Langerak; A Mendonça; E Macintyre; M Martin-Ayuso; O Hrusak; M B Vidriales; A Orfao
Journal:  Leukemia       Date:  2012-05-03       Impact factor: 11.528

4.  Bone marrow aspirate and biopsy: a pathologist's perspective. II. interpretation of the bone marrow aspirate and biopsy.

Authors:  Roger S Riley; David Williams; Micaela Ross; Shawn Zhao; Alden Chesney; Bradly D Clark; Jonathan M Ben-Ezra
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

5.  Immunophenotypic profile in acute infectious mononucleosis mimicking malignant lymphoproliferative disorder: a case report and review of literature.

Authors:  Prashant Tembhare; Manisha Ramani; Keerti Syed; Amar Das Gupta
Journal:  Indian J Hematol Blood Transfus       Date:  2010-09-30       Impact factor: 0.900

6.  Aberrant phenotypes in Kikuchi's disease.

Authors:  Xue-Jing Wei; Xiao-Ge Zhou; Jian-Lan Xie; Xiao-Dan Zheng; Yuan-Yuan Zheng
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

7.  Minimal detectable disease confirmed by flow cytometry and poor outcome after autologous stem cell transplantation in peripheral T-Cell lymphomas.

Authors:  J Gauthier; L Holmberg; D Wu; W Bensinger; A K Gopal; O Press; D Maloney; D J Green; B G Till; D Byelykh; A Shustov
Journal:  Bone Marrow Transplant       Date:  2016-10-24       Impact factor: 5.483

8.  Targeting the T cell receptor β-chain constant region for immunotherapy of T cell malignancies.

Authors:  Paul M Maciocia; Patrycja A Wawrzyniecka; Brian Philip; Ida Ricciardelli; Ayse U Akarca; Shimobi C Onuoha; Mateusz Legut; David K Cole; Andrew K Sewell; Giuseppe Gritti; Joan Somja; Miguel A Piris; Karl S Peggs; David C Linch; Teresa Marafioti; Martin A Pule
Journal:  Nat Med       Date:  2017-11-13       Impact factor: 53.440

9.  Massive expansion of EBV+ monoclonal T cells with CD5 down regulation in EBV-associated haemophagocytic lymphohistiocytosis.

Authors:  Ming-Tsan Lin; Hui-Mei Chang; Chang-Jen Huang; Woan-Ling Chen; Chi-Yung Lin; Ching-Yang Lin; Shih-Sung Chuang
Journal:  J Clin Pathol       Date:  2007-01       Impact factor: 3.411

10.  PhenoGraph and viSNE facilitate the identification of abnormal T-cell populations in routine clinical flow cytometric data.

Authors:  Joseph A DiGiuseppe; Jolene L Cardinali; William N Rezuke; Dana Pe'er
Journal:  Cytometry B Clin Cytom       Date:  2017-09-26       Impact factor: 3.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.